DAVID C. GRIFFITH,KEITH A. BOSTIAN,MARK W. SURBER,MICHAEL N. DUDLEY,OLGA RODNY,GRIFFITH DAVID C,BOSTIAN KEITH A,SURBER MARK W,DUDLEY MICHAEL N,RODNY OLGA
申请号:
BRPI0920026
公开号:
BRPI0920026A2
申请日:
2009.10.06
申请国别(地区):
BR
年份:
2015
代理人:
摘要:
The present invention relates to the field of antimicrobial agents. In particular, the present invention relates to the use of aerosolized fluoroquinolones formulated with divalent or trivalent cations and having improved pulmonary availability for the treatment and management of bacterial infections of the lung and upper respiratory tract.